Cerebral venous thrombosis: recurrence with fatal course.
van den Berg
J S
JS
Boerman
R H
RH
vd Stolpe
A
A
Kremer
H P
HP
D000074:Acenocoumarol / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D002533:Cerebral Angiography; D002544:Cerebral Infarction / Q000209:etiology; D004828:Epilepsies, Partial / Q000209:etiology; D017809:Fatal Outcome; D020022:Genetic Predisposition to Disease; D006261:Headache / Q000209:etiology; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006849:Hydrocephalus / Q000209:etiology / Q000601:surgery; D008297:Male; D012008:Recurrence; D012851:Sinus Thrombosis, Intracranial / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000235:genetics / Q000517:prevention & control; D017287:Ventriculoperitoneal Shunt
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin; D000074:Acenocoumarol